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What is the central question of this study? 
Do obese women with relatively high whole-body iron stores exhibit elevated in vivo rates of fatty 
acid (FA) release from adipose tissue compared with a well-matched cohort of obese women with 
relatively low iron stores? 
 
What is the main finding and its importance? 
Obese women with high plasma [ferritin] (a marker of whole-body iron stores) had greater FA 
mobilization, lipolytic activation in adipose tissue, and insulin resistance (IR) compared to obese 
women with lower plasma [ferritin]. As elevated FA mobilization is intimately linked with the 
development of IR, these findings suggest that elevated iron stores may contribute to IR in obesity by 
increasing systemic FA availability. 
ABSTRACT 
High rates of fatty acid (FA) mobilization from adipose tissue are associated with insulin resistance 
(IR) in obesity. In vitro evidence suggests that iron stimulates lipolysis in adipocytes but whether iron 
is related to in vivo FA mobilization is unknown. We hypothesized that plasma ferritin concentration 
([ferritin]), a marker of body iron stores, would be positively associated with FA mobilization. We 
measured [ferritin], FA rate of appearance into systemic circulation (FA Ra; stable isotope dilution), 
key adipose tissue lipolytic proteins, and IR (hyperinsulinemic-euglycemic clamp) in 20 obese, 
premenopausal women. [Ferritin] was correlated with FA Ra (r=0.65;p=0.002) and IR 
(r=0.57;p=0.008); these relationships remained significant after controlling for BMI and plasma [C-
reactive protein] ([CRP], a marker of systemic inflammation) in multiple regression analyses. We then 
stratified subjects into tertiles based on [ferritin] to compare subjects with ―High-ferritin‖ vs. ―Low-
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ferritin‖. Plasma [hepcidin] was more than 5-fold greater in High-ferritin vs. Low-ferritin (p<0.05) but 
there was no difference in plasma [CRP] between groups, indicating that the large difference in 
plasma [ferritin] reflects a difference in iron stores, not systemic inflammation. We found that FA Ra, 
adipose protein abundance of hormone sensitive lipase and adipose triglyceride lipase, and IR were 
significantly greater in High-ferritin vs. Low-ferritin (all p<0.05). These data provide the first 
evidence linking iron and in vivo FA mobilization and suggest that elevated iron stores may contribute 
to IR in obesity by increasing systemic FA availability. 
INTRODUCTION 
Accumulating evidence suggests that dysregulated iron homeostasis contributes to metabolic 
dysfunction in obesity (Gabrielsen et al. 2012; Moreno-Navarrete et al. 2014; Orr et al. 2014), but the 
mechanisms linking iron and metabolic health remain incompletely understood
 
(Fernández-Real et al. 
2015). High rates of adipose tissue lipolysis and fatty acid (FA) release into the systemic circulation 
are associated with insulin resistance in obesity (Van Pelt et al. 2017) and some ex vivo/in vitro 
evidence indicates that iron increases lipolysis in adipocytes (Rumberger et al. 2004; Chirumbolo et 
al. 2015). There is also some epidemiological evidence linking markers of iron metabolism with 
plasma FA concentrations
 
(Wlazlo et al. 2013), and it has been suggested that iron-mediated lipolysis 
and FA release may contribute to impaired insulin sensitivity in obesity
 
(Rumberger et al. 2004; 
Chirumbolo et al. 2015; Wlazlo et al. 2013). However, the relationship between iron and in vivo FA 
release has not been examined. The purpose of this study was to determine if plasma ferritin 
concentration ([ferritin]), a marker of total body iron stores
 
(Worwood 2007), is positively associated 
with elevated rates of FA release from adipose tissue in obese, premenopausal women.  
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METHODS 
Ethical Approval  
This study was part of a larger investigation of the relationship between FA mobilization and 
insulin resistance in obese adults. Some of this study’s methods have been reported elsewhere (Van 
Pelt et al. 2017) but are briefly repeated here for convenience. All findings reported in this paper are 
novel. This study conformed to the standards set by the latest version of the Declaration of Helsinki, 
was registered at clinicaltrials.gov (NCT01452048), and was approved by the University of Michigan 
Institutional Review Board (HUM00051537). All participants provided written, informed consent.  
We studied 20 obese, premenopausal women with plasma [ferritin] within the clinically-
normal range (12-200 ng/mL; Worwood 2007). Participants were weight-stable for 6 months, not 
pregnant or breastfeeding, and not taking medications/supplements known to affect their metabolism. 
Participants were studied after an overnight fast during the follicular phase of their menstrual cycle. 
We collected a baseline blood sample and a subcutaneous abdominal adipose tissue sample, under 
local anesthetic
 
(Van Pelt et al. 2017). FA rate of appearance into systemic circulation (FA Ra) was 
assessed using 
13
C palmitate isotope dilution as detailed elsewhere (Van Pelt et al. 2017). Briefly, 
after collecting the baseline blood and adipose tissue samples, 
13
C palmitate was infused at a rate of 
0.04 mol/kg/min for 1 hour. After 45 minutes, we collected 3 blood samples separated by 5 minutes 
for the determination of the tracer-tracee ratio (TTR) of 
13
C/
12
C palmitate in plasma for subsequent 
FA Ra calculations
 
(Patterson et al. 1998). Insulin resistance was assessed using a 2-hour primed, 
hyperinsulinemic-euglycemic clamp—insulin was infused at a rate of 100 mU/m2/min and insulin 
sensitivity (the inverse of insulin resistance) was determined as the steady-state glucose infusion rate 
at the end of the clamp period divided by fat free mass (assessed via dual-energy X-ray 
absorptiometry).  
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Analytical Methods 
Hemoglobin concentration ([hemoglobin]) and hematocrit were assessed by the University of 
Michigan Pathology Laboratory. Fasting plasma concentrations of glucose, triglycerides, and 
cholesterol were measured using colorimetric assays and fasting plasma insulin concentration was 
measured via radioimmunoassay (Van Pelt et al. 2017). Enzyme-linked immunosorbent assays were 
used for the measurement of plasma concentrations of ferritin (Abcam Ab108837), high-sensitivity C-
reactive protein ([CRP], Calbiotech CR120C), soluble transferrin receptor ([sTfr], R&D Systems 
DTFR1), and hepcidin ([hepcidin], R&D Systems DHP250). For our FA Ra analysis, palmitate TTR, 
as well as plasma concentrations of palmitate and total FA were all determined using GC/MS 
(Patterson et al. 1998; Patterson et al. 1999).  Palmitate Ra was calculated from TTR using the steady-
state Steele equation
 
(Steele 1959) and FA Ra was calculated by dividing palmitate Ra by the 
fractional contribution of palmitate to total FA concentration. Standard immunoblotting techniques
 
(Van Pelt et al. 2017) were used to quantify the protein abundance of hormone sensitive lipase (HSL; 
#4107 Cell Signaling), phosphorylated HSL (p-HSL
ser660
; #4126 Cell Signaling), adipose triglyceride 
lipase (ATGL; #2138 Cell Signaling), and phosphorylated ATGL (p-ATGL
ser406
, kind gift of Dr. 
Matthew Watt, University of Melbourne). The ATGL antibody recognized a doublet of ~50 and 54 
kDa, as has been reported in previous studies (Wang et al. 2013; Schreiber et al. 2017). A single box 
was drawn around both bands for ATGL quantification. Protein expression was normalized to total 
protein stain (Memcode, Thermofisher). 
 
Statistics 
All data are presented as meanSD. Non-normally distributed variables ([sTfr], [Triglycerides], and 
p-HSL protein expression) were log-transformed prior to statistical analyses. Simple and multiple 
linear regressions were performed to examine relationships between variables. For group comparisons 
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between the highest and lowest tertiles of plasma [ferritin], homogeneity of variance was tested 
(Levene’s test) and unpaired t-tests were performed. The level of significance was set at p0.05 
(SPSS version 24). 
 
RESULTS 
Plasma [Ferritin] and Group Stratification 
Plasma [ferritin] in our subjects ranged from 23-197 ng/mL, which is within the clinically 
normal range
 
(Worwood 2007). We stratified subjects into tertiles for comparisons between subjects 
with high-normal plasma [ferritin] (―High-ferritin‖; 14428 ng/ml; n=6) vs. low-normal plasma 
[ferritin] (―Low-ferritin‖; 3613 ng/mL; n=6). The High-ferritin and Low-ferritin groups were well-
matched for age, anthropometric characteristics, and fasting plasma concentrations of glucose, insulin, 
triglycerides, and cholesterol (Table 1). By design, there was a large (~4-fold) difference in plasma 
[ferritin] between groups. Hepcidin, a liver-secreted hormone described as the master regulator of iron 
homeostasis, increases in response to high iron stores (Coffee & Ganz 2017); consistent with this, we 
found that plasma [hepcidin] was more than 5-fold greater in High-ferritin vs. Low-ferritin. Systemic 
inflammation can influence [ferritin] and [hepcidin] but plasma [CRP] did not differ between groups, 
suggesting that the difference in plasma [ferritin] between groups reflects a large difference in body 
iron stores without a difference in a key marker of systemic inflammation. Basic markers of 
erythropoiesis ([hemoglobin], hematocrit, and [sTfr]) were also similar between groups (Table 1).  
 
Fatty Acid Mobilization 
FA Ra (mol/kg fat mass/min) was more than 80% greater in High-ferritin vs. Low-ferritin 
(p=0.02; Figure 1A). The large between-group difference in FA Ra remained significant when 
  
 
This article is protected by copyright. All rights reserved. 
 
expressed in absolute terms (696191 vs. 413133 mol/min, p=0.01) or normalized to fat-free mass 
(13.73.6 vs. 8.62.0 mol/kg/min, p=0.01). Accompanying the greater FA Ra in High-ferritin vs. 
Low-ferritin, total protein abundance of HSL and ATGL and the ratio of p-HSL
ser660
:HSL (a marker of 
elevated lipolytic activation) were all significantly greater in High-ferritin (p<0.05; Figure 1B). There 
were no differences in the ratio of p-ATGL
ser406
:ATGL (Figure 1B). Across all 20 subjects, plasma 
[ferritin] was significantly correlated with FA Ra (r=0.65; p=0.002; Figure 1C). Importantly, using 
multiple regression analyses, plasma [ferritin] remained independently correlated with FA Ra even 
when BMI and [CRP] were included as covariates (overall model R=0.67, p=0.02; [ferritin] 
rpartial=0.67, p=0.003; BMI rpartial=-0.073, p=0.78; [CRP] rpartial=-0.13, p=0.62).  
 
Insulin Sensitivity 
Whole-body insulin sensitivity was nearly 40% lower in High-ferritin vs. Low-ferritin 
(p=0.02; Figure 1D). Across all 20 subjects, plasma [ferritin] was negatively correlated with insulin 
sensitivity (r=-0.57; p=0.008; Figure 1E). Using multiple regression analyses, plasma [ferritin] 
remained independently correlated with insulin sensitivity when BMI and [CRP] were included as 
covariates (overall model R=0.69, p=0.02; [ferritin] rpartial=-0.62, p=0.01; BMI rpartial=-0.28, p=0.28; 
[CRP] rpartial=-0.16, p=0.53).  
 
DISCUSSION 
The major novel finding of this study was that plasma [ferritin] was linked with elevated FA 
Ra in obese, premenopausal women. These data are the first to demonstrate a relationship between 
iron stores and in vivo FA mobilization. Importantly, our findings also suggest that an elevation in 
systemic FA mobilization in obese adults with relatively high plasma [ferritin] may contribute to 
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whole-body insulin resistance. Together, these findings suggest that iron stores influence FA 
metabolism and insulin resistance in obesity, even among individuals with clinically-normal plasma 
[ferritin]. 
Circulating [ferritin] is widely used as a biomarker of body iron stores in clinical and research 
settings (Worwood 2007). However, it is known that systemic inflammation can augment plasma 
[ferritin] (Gabay & Kushner 1999), which can influence the interpretation of [ferritin] as a marker of 
body iron stores. For this reason, it is common to assess circulating [CRP] in conjunction with 
[ferritin] to determine if observed [ferritin] patterns are driven by inflammation. In the present study, 
we found no difference in [CRP] between High-ferritin and Low-ferritin, and the relationships 
between [ferritin] and FA Ra and insulin resistance persisted after controlling for [CRP] in multiple 
regression analyses. Importantly, the relationship between [ferritin] and insulin resistance has 
repeatedly been shown to remain independent of [CRP] (Wlazlo et al. 2015; Jehn et al. 2004). We 
recognize that [CRP] is only one marker of systemic inflammation and we cannot completely dismiss 
the possible influence of inflammation on [ferritin] in our subjects.  
The mechanisms linking iron and insulin resistance remain incompletely understood, but our 
findings suggest that iron-mediated FA mobilization may be a key underlying mechanism. Previous 
studies reported that ex vivo and in vitro treatment of murine adipocytes with iron increased glycerol 
release (Rumberger et al. 2004; Chirumbolo et al. 2015), suggesting the possibility that iron may 
directly or indirectly activate ATGL and/or HSL, the two primary enzymes catalyzing triglyceride 
hydrolysis (i.e., lipolysis). Gene expression of HSL was recently reported to be significantly increased 
(and the increase in ATGL expression was nearly statistically significant) in mice after four weeks of 
dietary iron supplementation
 
(Katsumura et al. 2017) but to our knowledge, the influence of iron on 
lipase protein activation/abundance has not been previously examined. Our findings that total protein 
abundance of both HSL and ATGL and the ratio of p-HSL
ser660
:HSL were significantly greater in 
High-ferritin vs. Low-ferritin suggest that iron may increase lipase protein abundance and activation. 
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Iron is a potent inducer of reactive oxygen species (ROS), which have been found to increase 
adipocyte HSL activation in vitro
 
(Krawczyk et al. 2012). Based on these findings, our working 
hypothesis is that elevated iron increases ROS signaling, thereby increasing lipase activity and FA Ra, 
resulting in impaired insulin sensitivity.  
Our cross-sectional study design enabled us to compare obese subjects with widely differing 
iron stores that were otherwise well-matched. We hypothesize that iron stimulates lipolysis, resulting 
in elevated FA Ra, but we cannot rule out the possibility that the converse is true (i.e., elevated FA Ra 
may increase iron uptake and storage) or that the association between [ferritin] and FA Ra may be 
mediated by other factors. Additional studies are needed to determine whether iron stores and FA Ra 
are indeed causally related. Future studies are also needed to examine whether the observed 
relationships between iron, FA mobilization, and insulin resistance in obese, premenopausal women 
hold true in other populations. 
In summary, we have provided the first evidence linking iron stores and in vivo FA 
mobilization. These findings add to the growing body of evidence indicating that iron stores influence 
metabolic health, even among individuals with normal iron stores. Future studies are warranted to 
determine if lowering iron stores is a potential countermeasure to reduce FA mobilization and 
improve insulin sensitivity in obese adults. 
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Table 1. Anthropometric and clinical measures in Low-Ferritin vs. High-Ferritin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are presented as mean ± SD. *p0.05. 
 
Low-Ferritin  
(n = 6) 
High-Ferritin 
(n = 6) 
P-Value 
    
Age (years) 34 ± 11 33 ± 7 0.80 
Body Mass (kg) 96 ± 11 98 ± 9 0.73 
Body Mass Index (kg/m2) 35 ± 2 37 ± 3 0.25 
Body Fat (%) 51 ± 3 48 ± 6 0.36 
Fat Mass (kg) 49 ± 8 47 ± 9 0.73 
Fat Free Mass (kg) 47 ± 5 51 ± 6 0.27 
    
Fasting [Glucose] (mM) 4.7 ± 0.5 4.5 ± 0.7 0.61 
Fasting [Insulin] (U/mL) 14 ± 10 18 ± 6 0.40 
Fasting [Triglycerides] (mg/dL) 53 ± 20 61 ± 37 0.83 
Fasting [Cholesterol] (mg/dL) 159 ± 45 167 ± 16 0.70 
    
Plasma [Ferritin] (ng/mL) 36 ± 13 144 ± 28 0.000007* 
Plasma [Hepcidin] (ng/mL) 34 ± 54 184 ± 118 0.02* 
Plasma [CRP] (mg/dL) 0.9 ± 0.8 1.2 ± 0.8 0.48 
[Hemoglobin] (g/dL) 12.2 ± 1.2 12.4 ± 0.3 0.64 
Hematocrit (%) 37 ± 3 37 ± 1 0.91 
Plasma [sTfr] (nM) 28 ± 14 19 ± 5 0.21 
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FIGURE CAPTIONS 
Figure 1. A) Fatty acid rate of appearance (FA RA) in Low-Ferritin (closed circles) vs. High-Ferritin 
(open circles). B) Relative protein abundance of lipolytic proteins in adipose tissue; data were 
normalized to total protein stain (Memcode) and expressed relative to the mean of the Low-Ferritin 
group. Western blot images show all individual data for subjects in the Low-Ferritin and High-Ferritin 
groups (for each protein, all subjects were run on a single gel with a molecular weight marker after the 
4
th
 sample). A representative image of the total protein stain is shown. Images were processed using 
Image J; image adjustments were limited to changes in brightness and contrast to optimize 
visualization and were performed uniformly on the whole image. C) Correlation between plasma 
[ferritin] and FA Ra across all subjects. D) Insulin sensitivity (glucose infusion rate; GIR) in Low-
Ferritin vs. High-Ferritin. E) Correlation between plasma [ferritin] and insulin sensitivity across all 
subjects. Data in panels A, B, and D are presented as mean  SD with individual data shown. 
*p0.05. 
 
 
